Institutional investors in Trevi Therapeutics, Inc. (NASDAQ:TRVI) see US$40m decrease in market cap last week, although long-term gains have benefitted them.

By Yahoo! Finance | Aug 7, 2024 at 07:32 AM EST

Ownership research and analyst forecasts data provide insights into stock opportunities. Institutions hold 37% stake in Trevi Therapeutics, impacting market cap fluctuations. Hedge funds and private equity firms also play significant roles in influencing company decisions.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.